164 related articles for article (PubMed ID: 24463559)
1. Screening method to evaluate point-of-care human chorionic gonadotropin (hCG) devices for susceptibility to the hook effect by hCG β core fragment: evaluation of 11 devices.
Nerenz RD; Song H; Gronowski AM
Clin Chem; 2014 Apr; 60(4):667-74. PubMed ID: 24463559
[TBL] [Abstract][Full Text] [Related]
2. Using a simulation model to assess risk of false negative point-of-care urinary human chorionic gonadotropin device results due to high-dose hook interference.
Milhorn D; Korpi-Steiner N
Clin Biochem; 2015 Feb; 48(3):99-104. PubMed ID: 25448030
[TBL] [Abstract][Full Text] [Related]
3. Characterizing urinary hCGβcf patterns during pregnancy.
Nerenz RD; Yarbrough ML; Stenman UH; Gronowski AM
Clin Biochem; 2016 Jul; 49(10-11):777-81. PubMed ID: 27087510
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a semi-quantitative pregnancy device for susceptibility to interference caused by hCGβcf.
Nerenz RD; Butch AW; Ashby L; Woldemariam GA; Gronowski AM
Clin Biochem; 2015 Aug; 48(12):815-7. PubMed ID: 25916816
[TBL] [Abstract][Full Text] [Related]
5. Estimating the hCGβcf in urine during pregnancy.
Nerenz RD; Butch AW; Woldemariam GA; Yarbrough ML; Grenache DG; Gronowski AM
Clin Biochem; 2016 Feb; 49(3):282-6. PubMed ID: 26541857
[TBL] [Abstract][Full Text] [Related]
6. Falsely decreased human chorionic gonadotropin (hCG) results due to increased concentrations of the free beta subunit and the beta core fragment in quantitative hCG assays.
Grenache DG; Greene DN; Dighe AS; Fantz CR; Hoefner D; McCudden C; Sokoll L; Wiley CL; Gronowski AM
Clin Chem; 2010 Dec; 56(12):1839-44. PubMed ID: 20930131
[TBL] [Abstract][Full Text] [Related]
7. Analytical sensitivity of four commonly used hCG point of care devices.
Kamer SM; Foley KF; Schmidt RL; Greene DN
Clin Biochem; 2015 Apr; 48(6):448-52. PubMed ID: 25549977
[TBL] [Abstract][Full Text] [Related]
8. Limitations in qualitative point of care hCG tests for detecting early pregnancy.
Greene DN; Schmidt RL; Kamer SM; Grenache DG; Hoke C; Lorey TS
Clin Chim Acta; 2013 Jan; 415():317-21. PubMed ID: 23159297
[TBL] [Abstract][Full Text] [Related]
9. Urinary human chorionic gonadotropin isoform concentrations in doping control samples.
Butch AW; Woldemariam GA
Drug Test Anal; 2016 Nov; 8(11-12):1147-1151. PubMed ID: 27594536
[TBL] [Abstract][Full Text] [Related]
10. Point-of-care and over-the-counter qualitative human chorionic gonadotropin (hCG) devices remain susceptible to false-negative results caused by excess hCG β core fragment.
Nerenz RD; Gronowski AM
Clin Chem; 2013 Nov; 59(11):1672-4. PubMed ID: 23985957
[No Abstract] [Full Text] [Related]
11. Significance of pregnancy test false negative results due to elevated levels of β-core fragment hCG.
Johnson S; Eapen S; Smith P; Warren G; Zinaman M
J Immunoassay Immunochem; 2017; 38(4):449-455. PubMed ID: 28521601
[TBL] [Abstract][Full Text] [Related]
12. False-negative results in point-of-care qualitative human chorionic gonadotropin (hCG) devices due to excess hCGbeta core fragment.
Gronowski AM; Cervinski M; Stenman UH; Woodworth A; Ashby L; Scott MG
Clin Chem; 2009 Jul; 55(7):1389-94. PubMed ID: 19395437
[TBL] [Abstract][Full Text] [Related]
13. Qualitative point-of-care and over-the-counter urine hCG devices differentially detect the hCG variants of early pregnancy.
Cervinski MA; Lockwood CM; Ferguson AM; Odem RR; Stenman UH; Alfthan H; Grenache DG; Gronowski AM
Clin Chim Acta; 2009 Aug; 406(1-2):81-5. PubMed ID: 19477170
[TBL] [Abstract][Full Text] [Related]
14. Urine reference intervals for human chorionic gonadotropin (hCG) isoforms by immunoextraction-tandem mass spectrometry to detect hCG use.
Butch AW; Ahrens BD; Avliyakulov NK
Drug Test Anal; 2018 Jun; 10(6):956-960. PubMed ID: 29098788
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the CLINITEST® human chorionic gonadotropin (hCG) pregnancy test for susceptibility to the hook effect by the hCG β core fragment.
Ledden DJ; Novamo AK; Schulman LS
Clin Chem; 2014 Dec; 60(12):1578-80. PubMed ID: 25248572
[No Abstract] [Full Text] [Related]
16. Analytical and Clinical Evaluation of the NOWDiagnostics ADEXUSDx Human Chorionic Gonadotropin Test Using Whole Blood.
Nerenz RD; Bell JR; Montes de Oca N; Short J; Mims T; Cleeton PA; Daniel Moore J; Humphries RL
J Appl Lab Med; 2016 Jul; 1(1):67-76. PubMed ID: 33626807
[TBL] [Abstract][Full Text] [Related]
17. "Hook-like effect" causes false-negative point-of-care urine pregnancy testing in emergency patients.
Griffey RT; Trent CJ; Bavolek RA; Keeperman JB; Sampson C; Poirier RF
J Emerg Med; 2013 Jan; 44(1):155-60. PubMed ID: 21835572
[TBL] [Abstract][Full Text] [Related]
18. Immunoextraction-tandem mass spectrometry method for measuring intact human chorionic gonadotropin, free β-subunit, and β-subunit core fragment in urine.
Woldemariam GA; Butch AW
Clin Chem; 2014 Aug; 60(8):1089-97. PubMed ID: 24899693
[TBL] [Abstract][Full Text] [Related]
19. hCGbeta core fragment is a metabolite of hCG: evidence from infusion of recombinant hCG.
Norman RJ; Buchholz MM; Somogyi AA; Amato F
J Endocrinol; 2000 Mar; 164(3):299-305. PubMed ID: 10694369
[TBL] [Abstract][Full Text] [Related]
20. Persistently elevated serum concentrations of human chorionic gonadotropin (hCG).
Collazo Abal C; Fernández Marcos MC; Casado Rey P; Vázquez Caamaño MP; Alfthan H; Koistinen H; Stenman UH
Clin Chem Lab Med; 2023 Oct; 61(11):2028-2032. PubMed ID: 37279342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
